| Quarter (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| 13F holders | Current |
|---|---|
| Total holders | 67 |
| Opened positions | 22 |
| Closed positions | 4 |
| Increased positions | 16 |
| Reduced positions | 17 |
| 13F shares | Current |
|---|---|
| Total value | 74.61 bn |
| Total shares | 18.21 mm |
| Total puts | 78.30 k |
| Total calls | 24.40 k |
| Total put/call ratio | 3.2 |
| Largest owners | Shares | Value |
|---|---|---|
| Israel Biotech Fund II | 5.72 mm | $9.15 mm |
| Deep Insight Limited Partnership | 5.72 mm | $9.15 mm |
| Access Industries | 1.48 mm | $30.12 mm |
| Investor AB (publ) | 872.09 k | $15.75 bn |
| Molnlycke Health Care AB | 872.09 k | $17.73 mm |
| Yelin Lapidot Holdings Management | 750.74 k | $13.56 bn |
| Rosalind Advisors | 628.05 k | $11.34 bn |
| BlackRock | 433.00 k | $7.82 bn |
| Rosenberg Lior | 251.34 k | $0.00 |
| Balyasny Asset Management | 165.74 k | $2.99 bn |
